News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good guess , but history shows this company burns cash, and ~$103mm could help if approved…they will still come to market for raise, but hopefully at higher levels, especially if Sickle Cell approved..
FYI:
FDA panel greenlights approval of first human drug using CRISPR
Food and Drug Administration (FDA) advisers cleared the way for the first FDA approval of a human drug using CRISPR technology.
The news: FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee said exa-cel, the sickle cell gene therapy developed by BIO members Vertex Pharmaceuticals and CRISPR Therapeutics, is safe for clinical use.
Been quite the sell-off, as you predicted. But with yesterday's 8-K w the pre-sale of the PRV, this is looking really nice.
BLUE trying to break the $4 resistance
And IT is in! Edit: Going back to review, other notices like this I received in April 4th for two other tickers, and noticed there was the same notice from April 4 23 for BLUE. Still bullish AF!
[The maintenance requirement for your holding below has changed. This may increase or decrease your available purchasing power.
Account: XXXX-ZZZZ
Holding Ticker Symbol: BLUE
Holding Description: BLUEBIRD BIO INC COM
New requirement: 100%
Old requirement: 25%]
Bear raid over soon, me thinks.
2 approved Drugs, Priority review and Pdufa date in Q4 on Sickle Cell, and this pig can’t move out of the sloppp!! Wtf
Prob sold off bcuz Auth. shares doubling and near term Capital raise again!! Dilution should be in its corporate name!! Certainly in its DNA
Crazy action today. Waiting patiently for a brokerage notice about margin requirements for BLUE.
Continuously.
If we can get this PR , should move high single digits.. then sell off on Capital raise, then double digits!! Otherwise, down she goes to $2-3ish!
• The Company anticipates BLA acceptance of lovo-cel for SCD in Q2 2023.
I expect *new* news soon.
8K filing couple days ago showing $350mm shelf dinging ticker
That's a pretty nice 10Q and a terribly sweet 8k today.
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=317472177&type=HTML&symbol=BLUE&cdn=49eb2e78599a3f8993e1dbd77103d6c4&companyName=bluebird+bio+Inc.&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2023-05-09
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=317472175&type=PDF&symbol=BLUE&cdn=a27bb9bb8a132409a5d38d92346a9d24&companyName=bluebird+bio+Inc.&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2023-05-09
["The first quarter of 2023 saw us continue to establish and scale the commercial model for ex-vivo gene therapy in the US through the
launches of ZYNTEGLO and SKYSONA and lay the foundation for revenue generation for years to come for bluebird," said Andrew
Obenshain, chief executive officer, bluebird bio. "Additionally, with the submission of the lovo-cel BLA for sickle cell disease in April,
bluebird has taken a pivotal step towards realizing its most significant opportunity yet -- bringing a transformative gene therapy to
individuals living with sickle cell disease."]
I have a similar position - 98,050 in the high $4 avg., from $3 -$7.6x.
BLUE will be 3/3. Patience.
Here is an example from a few accounts that hold Blue( cant show all, don’t need certain peeps to see, lol but it adds up to ~100k :)
Total value
Shares owned
Average cost
Today's gain/loss
$154,800.00
45,000.000
$5.59
+$3,600.00 (+2.38%)
Shares owned
Average cost
$17,200.00
5,000.000
$4.50
I have ~100,000 reasons why I’m hoping
So! Lol :)
I fully believe it will be 3 for 3.
This walk-down has been just amazing. For all the hype on manipulation and BKcy, I'm really surprised this doesn't have more attention.
Yep, they’ll be fine for a bit, but cash burn high with launch(s).. All good, Sickle cell goes thru, $30’s…funny, I posted (#225 day before offering and used ~100mm share count , lol ..
